Christopher E. Griffiths

Oxford Road
Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 481 publications

Global Disparities in Access to Dermatological Care.

Global Disparities in Access to Dermatological Care.

Journal: JAMA dermatology

Published: August 26, 2026

Associations between flavonoid intake, genetic risk of psoriasis, and psoriasis incidence: a prospective cohort study.

Associations between flavonoid intake, genetic risk of psoriasis, and psoriasis incidence: a prospective cohort study.

Journal: Food & function

Published: July 30, 2026

Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma.

Long-term Remission of Severe Psoriasis Following CD19 CAR-T Cell Therapy for Follicular Lymphoma.

Journal: Clinical and experimental dermatology

Published: April 01, 2026

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: March 29, 2026

Dermatological Disease at a Tertiary Military Hospital in Burundi: A Retrospective Review.

Dermatological Disease at a Tertiary Military Hospital in Burundi: A Retrospective Review.

Journal: International journal of dermatology

Published: March 16, 2026

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Journal: Clinical and translational science

Published: February 18, 2026

Global health and economic impact of expanding the WHO essential medicines list for psoriasis: a health economic modelling study.

Global health and economic impact of expanding the WHO essential medicines list for psoriasis: a health economic modelling study.

Journal: EClinicalMedicine

Published: February 12, 2026

Work impact of immune-mediated inflammatory skin diseases: A systematic review and meta-analysis.

Work impact of immune-mediated inflammatory skin diseases: A systematic review and meta-analysis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 05, 2026

Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).

Journal: The British journal of dermatology

Published: January 28, 2026

Mapping the global work-related impact of immune-mediated inflammatory skin diseases: a systematic review.

Mapping the global work-related impact of immune-mediated inflammatory skin diseases: a systematic review.

Journal: The Journal of investigative dermatology

Published: January 26, 2026

Mapping the global work-related impact of immune-mediated inflammatory skin diseases: A systematic review.

Mapping the global work-related impact of immune-mediated inflammatory skin diseases: A systematic review.

Journal: The Journal of investigative dermatology

Published: January 26, 2026

Skin care without borders: A UK-Myanmar teledermatology initiative.

Skin care without borders: A UK-Myanmar teledermatology initiative.

Journal: The Journal of investigative dermatology

Published: January 16, 2026

Showing 1-12 of 481

Last Updated: 09/26/2026